Literature DB >> 1387313

Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.

F Cabré1, J J Moreno, A Carabaza, E Ortega, D Mauleón, G Carganico.   

Abstract

Two anti-inflammatory peptides (antiflammins) corresponding to a high amino acid similarity region between lipocortin I and uteroglobin were tested for their ability to inhibit purified human synovial fluid phospholipase A2 (HSF-PLA2). No inhibitory activity was observed, even at such high concentrations of peptides as 50 microM. When antiflammins were preincubated with the enzyme and/or the substrate, no HSF-PLA2 inhibition was detected. In vivo anti-inflammatory activity of these peptides was evaluated in several experimental models of inflammation induced by carrageenan, croton-oil, oxazolone and Naja naja naja venom phospholipase A2 (PLA2). In contrast to the in vitro results, anti-inflammatory activity was observed in all tests, except when inflammation was induced by snake venom PLA2. Taken together, our results do not support the hypothesis that the in vivo anti-inflammatory effect of antiflammins is directly related to inhibition of PLA2 activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387313     DOI: 10.1016/0006-2952(92)90444-n

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Development of IFN-Stimulated Gene Expression from Embryogenesis through Adulthood, with and without Constitutive MDA5 Pathway Activation.

Authors:  Laura Bankers; Caitlin Miller; Guoqi Liu; Chommanart Thongkittidilok; James Morrison; Eric M Poeschla
Journal:  J Immunol       Date:  2020-04-10       Impact factor: 5.422

2.  Resonance assignment and secondary structure determination and stability of the recombinant human uteroglobin with heteronuclear multidimensional NMR.

Authors:  T Carlomagno; G Mantile; R Bazzo; L Miele; L Paolillo; A B Mukherjee; G Barbato
Journal:  J Biomol NMR       Date:  1997-01       Impact factor: 2.835

3.  Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein.

Authors:  A Peri; E Cordella-Miele; L Miele; A B Mukherjee
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

4.  Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.

Authors:  E C Landucci; E Antunes; J L Donato; R Faro; S Hyslop; S Marangoni; B Oliveira; G Cirino; G de Nucci
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

5.  Effect of manoalide on human 5-lipoxygenase activity.

Authors:  F Cabré; A Carabaza; N Suesa; A M García; E Rotllan; M Gómez; D Tost; D Mauleón; G Carganico
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

Review 6.  Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins.

Authors:  L Miele; E Cordella-Miele; G Mantile; A Peri; A B Mukherjee
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

7.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

8.  Inhibition of smooth muscle contraction and platelet aggregation by peptide 204-212 of lipocortin 5: an attempt to define some structure requirements.

Authors:  K G Mugridge; C Becherucci; L Parente; M Perretti
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.